CD262, Human (Tigatuzumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.

Search, find, compare suppliers for anti-CD262, Human (Tigatuzumab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityCD262, Human (Tigatuzumab biosimilar)
CloneTigatuzumab
Host SpeciesRecombinant
Reactive Specieshuman
IsotypeIgG1
Formatpurified
Size1mg, 5mg
Concentration1mg/ml
ApplicationsIF, IP, Neut, FuncS, ELISA, FCM
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionAnti-Human CD262 Recombinant Antibody (Tigatuzumab). Tigatuzumab (CS-1008) is a monoclonal antibod for the treatment of cancer. As of October 2009, a clinical trial for the treatment of pancreatic cancer, Phase II trials for colorectal cancer, non-small cell lung cancer, and ovarian cancer have been completed.
Immunogenn/a
Other NamesAnti-CD262 Recombinant Antibody, Research Grade Tigatuzumab, Anti-Human CD262 Recombinant Antibody(Tigatuzumab), CS-1008, TRA-8, Antibody Drug Analogues, Monoclonal Antibody, YR1151, Research Grade Biosimilars, Biosimilar Antibody
Gene, Accession #CAS: 918127-53-4
Catalog #YR1151
Priceplease inquire
Order / More InfoCD262, Human (Tigatuzumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Product Specific Referencesn/a
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806

info@kmdbioscience.com
Sales: sales@kmdbiosci.com

https://www.kmdbioscience.com

Profile of KMD BIOSCIENCE CO. LTD.

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.